1. Meningitis A in Burkina Faso (Video mit deutschen Untertiteln)

    03:14

    from Gavi, the Vaccine Alliance / Added

    106 Plays / / 0 Comments

    MenAfriVac ist ein neuer Impfstoff, der vor durch Meningokokken A verursachte Hirnhautentzündung schützt. Dieser Impftstoff soll Epidemien dieser Infektionskrankheit im sogenannten afrikanischen Meningitis-Gürtel verhindern. Der Meningitis-Gürtel beschreibt eine Region, die 25 Länder umfasst und sich vom Senegal an der Westküste quer über den Kontinent bis nach Äthiopien im Osten Afrikas zieht. Alle paar Jahre wird der Meningitis-Gürtel von einer Epidemie getroffen – die Fallzahlen machen 95 % der weltweiten Krankheitsbelastung mit Hirnhautentzündung aus. Die schlimmste Epidemie in jüngerer Zeit fand 1996 in dieser Region statt. 250.000 Menschen erkrankten. 25.000 Menschen starben, 50.000 behielten bleibende Behinderungen zurück. Meningitis-Epidemien haben allerdings über die tödlichen und gesundheitlich schwerwiegenden Folgen hinaus auch weitreichende gesellschaftspolitische Konsequenzen. Aus Angst vor der Krankheit kommen die Menschen nicht mehr zur Arbeit - was mit großen Kosten und finanziellen Ausfällen verbunden ist. Der Impfstoff MenAfriVac wurde vom Meningitis Impfprogramm (Meningitis Vaccine Project) entwickelt, einem gemeinsamen Projekt von PATH und der WHO. In Burkina Faso wurde der Impfstoff im November 2010 eingeführt. MenAfriVac kostet weniger als 50 US-Cent pro Dosis und ist zu 95 % wirksam. Die GAVI Alliance übernimmt den Großteil der Kosten, die bei der Einführung der Impfung entstehen. Wenn alle 25 Ländern im Meningitis-Gürtels die Impfung einführen, könnten bis 2015 236 Million Menschen mit MenAfriVac geimpft werden.

    + More details
    • Tanzania - April 2009

      02:51

      from Gavi, the Vaccine Alliance / Added

      29 Plays / / 0 Comments

      Tanzania has made significant progress over the past two decades to achieve and maintain macro-economic stability, becoming one of the best performers in Sub-Saharan Africa. In 2009, DTP3 coverage was 85%. For more information or for a shotlist, please contact GAVI directly.

      + More details
      • Rwanda health clinic (part 2) - November 2010

        02:54

        from Gavi, the Vaccine Alliance / Added

        23 Plays / / 0 Comments

        A highly successful partner, GAVI has made big strides with its immunisation. Babies born in Rwanda now receive life-saving vaccines against tuberculosis, diphtheria, tetanus, pertussis, polio, measles, Hib, hepatitis B and pneumococcal disease. For more information or for a shotlist, please contact GAVI directly.

        + More details
        • Rwanda health clinic (part 1) - November 2010

          04:04

          from Gavi, the Vaccine Alliance / Added

          39 Plays / / 0 Comments

          A highly successful partner, GAVI has made big strides with its immunisation. Babies born in Rwanda now receive life-saving vaccines against tuberculosis, diphtheria, tetanus, pertussis, polio, measles, Hib, hepatitis B and pneumococcal disease. For more information or for a shotlist, please contact GAVI directly.

          + More details
          • Nicaragua pneumococcal - December 2010

            01:56

            from Gavi, the Vaccine Alliance / Added

            18 Plays / / 0 Comments

            In December 2010, international leaders in global health joined the Nicaraguan government and hundreds of parents and children to celebrate the rollout of the new pneumococcal conjugate vaccine in the developing world less than a year after it was introduced in rich countries. The event marked the beginning of a global routine immunisation programme against pneumococcal disease in the developing world. For more information or for a shotlist, please contact GAVI directly.

            + More details
            • Nicaragua Rotavirus - December 2010

              02:03

              from Gavi, the Vaccine Alliance / Added

              28 Plays / / 0 Comments

              Nicaragua was one of the first countries to introduce the rotavirus vaccine. Rotavirus diarrhoea kills approximately 500,000 children under five every year. Research in Nicaragua showed that the vaccine prevented 60% of cases of severe rotavirus and halved the number of hospitalisations and emergency room visits. For more information or for a full shotlist, please contact GAVI directly.

              + More details
              • Kenya pneumococcal launch - February 2011

                02:19

                from Gavi, the Vaccine Alliance / Added

                26 Plays / / 0 Comments

                In February 2011, Kenya formally introduced the pneumococcal vaccine into its routine immunisation programme for all children. Every Pneumococcal disease currently kills every year more than half a million children before their fifth birthday. Kenya was the first African country to roll-out this pneumococcal conjugate vaccine which has been specially tailored to meet the needs of children in developing countries. For more information or for a full shotlist, please contact GAVI direct.

                + More details
                • Kenya health clinic - February 2011

                  02:01

                  from Gavi, the Vaccine Alliance / Added

                  17 Plays / / 0 Comments

                  GAVI's deputy CEO, Helen Evans, visits a health clinic in Nairobi to see for herself the benefits of the new pneumococcal vaccine launched in Kenya. In Feburary 2011, Kenya became the first African country to roll-out this pneumococcal conjugate vaccine which has been specially tailored to meet the needs of children in developing countries. For more information or for a full shotlist, please contact GAVI directly.

                  + More details
                  • GAVI Board Chair in Ethiopia - March 2011

                    04:40

                    from Gavi, the Vaccine Alliance / Added

                    17 Plays / / 0 Comments

                    In March 2011, GAVI Alliance Board Chair, Dagfinn Hoybraten, travelled to Ethiopia to see for himself GAVI's programmes in the field. Set to receive support worth US$ 100 million in 2011, Ethiopia has boosted its DTP3 coverage, a standard proxy indicator for immunisation, to 79% in 2009 from 56% in 2000, according to WHO / UNICEF data. For more information or for a full shotlist, please contact GAVI directly.

                    + More details
                    • Vietnam - October 2009

                      04:09

                      from Gavi, the Vaccine Alliance / Added

                      81 Plays / / 0 Comments

                      Vietnam is a showcase of what an effective immunisation programme can achieve. With support from development partners and donors including the GAVI Alliance, the country has used vaccines effectively to control vaccine-preventable diseases. Since 1990, the under-five mortality rate has dropped more than 40%. For more information or for a shotlist, please contact GAVI directly.

                      + More details

                      What are Tags?

                      Tags

                      Tags are keywords that describe videos. For example, a video of your Hawaiian vacation might be tagged with "Hawaii," "beach," "surfing," and "sunburn."